跳至主要内容
临床试验/EUCTR2006-000179-13-BE
EUCTR2006-000179-13-BE进行中(未招募)不适用

Validation of the methodology of serum creatinine measurement and the estimated glomular filtration ratio - URIS

niversity Hospital Ghent0 个研究点目标入组 30 人开始时间: 2006年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The subjects are adult volunteers participating in the study after an informed consent.
  • Subjects who meet all of the following criteria are eligible for this trial:
  • 1. Aged between 18 and 55 years.
  • 2. Normal weight as defined by a Body Mass Index of 18 to 30 kg/m2.
  • 3. Subject is competent and willing to sign informed consent form after being given all the detailed information about the study. Informed consent form signed voluntarily.
  • 4. The subjects must be in stable clinical condition, with stable serum creatinin at least for 6 months.
  • 5. Persons with different stage of chronic renal disease and without kidney disease (living donors) who need an evaluation of the GFR or Admitted volunteers who easily obtain urine samples.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subjects meeting one or more of the following criteria cannot be selected:
  • 1. Transplant patients
  • 2. Medication that will influence the serumcreatinine.
  • 3. Morbid obesity
  • 4. Pregnant, lactating females or females with childbearing potential without adequate contraception (use of oral contraceptives, IUD or condoms with spermicide).
  • 5. History of allergy or hypersensitivity to inulin
  • 6. Donation of blood in the 60 days preceding the first visit.
  • 7. Liver disease, heart failure, nephrotic syndrome.
  • 8. Patients in critically ill conditions.
  • 9. Malnutrition
  • 10. Postrenal kidney failure

研究者

发起方
niversity Hospital Ghent

相似试验